UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability

Thrombosis and haemostasis, 1995, Vol.73 (2), p.247-251

1995

Volltextzugriff (PDF)

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.622-631

2012

Volltextzugriff (PDF)

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Blood, 2012-07, Vol.120 (1), p.39-46

2012

Volltextzugriff (PDF)

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Blood, 2012-07, Vol.120 (1), p.47-55

2012

Volltextzugriff (PDF)

The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors

Thrombosis and haemostasis, 2001-12, Vol.86 (6), p.1435-1439

2001

Volltextzugriff (PDF)

Use of the Platelet Function Analyzer to minimize bleeding complications after renal biopsy

Thrombosis research, 2009-01, Vol.123 (3), p.515-522

2009

Volltextzugriff (PDF)

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1529-1537

2012

Volltextzugriff (PDF)

Prophylactic effect of recombinant factor VIIa in factor VII deficient patients

British journal of haematology, 2004-05, Vol.125 (4), p.494-499

2004

Volltextzugriff (PDF)

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population

British journal of haematology, 2005-10, Vol.131 (1), p.109-117

2005

Volltextzugriff (PDF)

Efficacy of Itraconazole in the Prevention of Fungal Infections Among Neutropenic Patients with Hematologic Malignancies and Intensive Chemotherapy. A Double Blind, Placebo Controlled Study

Leukemia & lymphoma, 1993, Vol.11 (5-6), p.353-358

1993

Volltextzugriff (PDF)

A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay

Thrombosis and haemostasis, 2002-08, Vol.88 (2), p.362

2002

Volltextzugriff (PDF)

Willebrand in the Netherlands: WiN Study. Background and Study Design

Blood, 2008-11, Vol.112 (11), p.4510-4510

2008

Volltextzugriff (PDF)

Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

Blood, 1998-03, Vol.91 (6), p.2015-2018

1998

Volltextzugriff (PDF)

Use of recombinant factor vlla (NovoSeven®) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia

Anesthesiology (Philadelphia), 2002-06, Vol.96 (6), p.1525-1527

2002

Volltextzugriff (PDF)

Rapid D-Dimer Assays to Exclude Deep Venous Thrombosis and Pulmonary Embolism: Current Status and New Developments

Seminars in thrombosis and hemostasis, 1998-01, Vol.24 (4), p.393-400

1998

Volltextzugriff (PDF)

Meloxicam, 15 mg/day, spares platelet function in healthy volunteers

Clinical pharmacology and therapeutics, 1999-10, Vol.66 (4), p.425-430

1999

Volltextzugriff (PDF)

Options and limitations of teicoplanin in febrile granulocytopenic patients

British journal of haematology, 1990-12, Vol.76 (s2), p.1-5

1990

Volltextzugriff (PDF)

Fibrinogen binding to the integrin αIIbβ3 modulates store-mediated calcium entry in human platelets

Blood, 2001-05, Vol.97 (9), p.2648-2656

2001

Volltextzugriff (PDF)

Use of Recombinant Activated Factor VII in Patients with Severe Coagulopathy and Bleeding

Anesthesiology (Philadelphia), 2003-04, Vol.98 (4), p.1027-1027

2003

Volltextzugriff (PDF)

Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton

Thrombosis and haemostasis, 1996-01, Vol.75 (1), p.182-189

1996

Volltextzugriff (PDF)

FACTOR VIIA DETERMINATION COMPARED TO D-DIMER IN DIAGNOSIS OF DEEP VENOUS THROMBOSIS

Thrombosis research, 1997-06, Vol.86 (5), p.423-426

1997

Volltextzugriff (PDF)

Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding

Anesthesiology (Philadelphia), 2003-04, Vol.98 (4), p.1025-1026

2003

Volltextzugriff (PDF)

Potential Sites of Infection That Develop in Febrile Neutropenic Patients

Leukemia & lymphoma, 1993, Vol.10 (6), p.461-467

1993

Volltextzugriff (PDF)

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

Journal of antimicrobial chemotherapy, 1990-06, Vol.25 (6), p.985-993

1990

Volltextzugriff (PDF)

Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia

Anesthesiology (Philadelphia), 2002-06, Vol.96 (6), p.1525-1527

2002

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(46)
Humans
(35)
Biological And Medical Sciences
(22)
Female
(21)
Male
(19)
Medical Sciences
(18)
Hematology
(17)
Adult
(14)
Middle Aged
(14)
Aged
(13)
Neurosciences & Neurology
(11)
Cardiovascular System & Cardiology
(10)
Peripheral Vascular Disease
(10)
Aged, 80 And Over
(9)
Neurosciences
(9)
Adolescent
(7)
Hematologic And Hematopoietic Diseases
(7)
Clinical Neurology
(6)
Factor Viii - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors

Use of the Platelet Function Analyzer to minimize bleeding complications after renal biopsy

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

Prophylactic effect of recombinant factor VIIa in factor VII deficient patients

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population

Efficacy of Itraconazole in the Prevention of Fungal Infections Among Neutropenic Patients with Hematologic Malignancies and Intensive Chemotherapy. A Double Blind, Placebo Controlled Study

A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay

Willebrand in the Netherlands: WiN Study. Background and Study Design

Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

Use of recombinant factor vlla (NovoSeven®) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia

Rapid D-Dimer Assays to Exclude Deep Venous Thrombosis and Pulmonary Embolism: Current Status and New Developments

Meloxicam, 15 mg/day, spares platelet function in healthy volunteers

Options and limitations of teicoplanin in febrile granulocytopenic patients

Fibrinogen binding to the integrin αIIbβ3 modulates store-mediated calcium entry in human platelets

Use of Recombinant Activated Factor VII in Patients with Severe Coagulopathy and Bleeding

Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton

FACTOR VIIA DETERMINATION COMPARED TO D-DIMER IN DIAGNOSIS OF DEEP VENOUS THROMBOSIS

Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding

Potential Sites of Infection That Develop in Febrile Neutropenic Patients

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia

Suchergebnisse filtern